Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China

CNS Neuroscience and Therapeutics

Volumn 20, Issue 1, 2014, Pages 32-39

  Yang, Chun Sheng ^a   Zhang, Da Qi ^a   Wang, Jing Hua ^a   Jin, Wei Na ^a   Li, Min Shu ^a   Liu, Jie ^a   Zhang, Cun Jin ^a   Li, Ting ^a   Shi, Fu Dong ^a,b   Yang, Li ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Anti aquaporin 4 antibody; Chinese; Clinical features; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4 ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; DEMYELINATING DISEASE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HICCUP; HUMAN; INFLAMMATORY DEMYELINATING DISORDER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; RETROSPECTIVE STUDY; SPINAL CORD LESION;

ANTI-AQUAPORIN 4 ANTIBODY; CHINESE; CLINICAL FEATURES; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA;

ADOLESCENT; ADULT; AGED; AQUAPORIN 4; AUTOANTIBODIES; BRAIN; CHINA; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DEMYELINATING DISEASES; FEMALE; HEK293 CELLS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE; NEUROMYELITIS OPTICA; OPTIC NEURITIS; RETROSPECTIVE STUDIES; SPINAL CORD; YOUNG ADULT;

EID: 84890548510     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12156     Document Type: Article

References (33)

1. Collongues N, de Seze J. Current and future treatment approaches for neuromyelitis optica. Ther Adv Neurol Disord 2011;4:111-121.
2. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-477.
3. Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005;65:1479-1482.
4. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003;2:117-127.
5. Osoegawa M, Kira J, Fukazawa T, et al. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: Nationwide survey results over 30 years. Mult Scler 2009;15:159-173.
6. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489.
7. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390-396.
8. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
9. Montalban X, Tintore M, Swanton J, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology 2010;74:427-434.
10. Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008;65:913-919.
11. Bizzoco E, Lolli F, Repice AM, et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 2009;256:1891-1898.
12. Asgari N, Lillevang ST, Skejoe HP, Falah M, Stenager E, Kyvik KO. A population-based study of neuromyelitis optica in Caucasians. Neurology 2011;76:1589-1595.
13. Siritho S, Nakashima I, Takahashi T, Fujihara K, Prayoonwiwat N. AQP4 antibody-positive Thai cases: Clinical features and diagnostic problems. Neurology 2011;77:827-834.
14. Chang KH, Lyu RK, Chen CM, et al. Clinical characteristics of multiple sclerosis in Taiwan: A cross-sectional study. Mult Scler 2006;12:501-506.
15. Lau KK, Wong LK, Li LS, Chan YW, Li HL, Wong V. Epidemiological study of multiple sclerosis in Hong Kong Chinese: Questionnaire survey. Hong Kong Med J 2002;8:77-80.
16. Cheng Q, Miao L, Zhang J, et al. A population-based survey of multiple sclerosis in Shanghai, China. Neurology 2007;68:1495-1500.
17. Mealy MA, Wingerchuk DM, Greenberg BM, Levy M. Epidemiology of neuromyelitis optica in the United States: A multicenter analysis. Arch Neurol 2012;69:1176-1180.
18. Collongues N, Marignier R, Zephir H, et al. Neuromyelitis optica in France: A multicenter study of 125 patients. Neurology 2010;74:736-742.
19. Sahraian MA, Moinfar Z, Khorramnia S, Ebrahim MM. Relapsing neuromyelitis optica: Demographic and clinical features in Iranian patients. Eur J Neurol 2010;17:794-799.
20. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004;364:2106-2112.
21. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007;130:1206-1223.
22. Huppke P, Bluthner M, Bauer O, et al. Neuromyelitis optica and NMO-IgG in European pediatric patients. Neurology 2010;75:1740-1744.
23. Chan KH, Kwan JS, Ho PW, Ho JW, Chu AC, Ramsden DB. Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: Comparison between tissue-based and cell-based indirect immunofluorescence assays. J Neuroinflammation 2010;7:50-58.
24. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: A study on antibody titre. Brain 2007;130:1235-1243.
25. Kim W, Park MS, Lee SH, et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler 2010;16:1229-1236.
26. Chan KH, Ramsden DB, Yu YL, et al. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Eur J Neurol 2009;16:310-316.
27. Chang KH, Lyu RK, Chen CM, et al. Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-Aquaporin 4 antibodies. Mult Scler 2013;19:299-307.
28. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006;59:566-569.
29. Kim SH, Kim SM, Vincent A, et al. Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis. J Neurol 2010;257:920-925.
30. Scott TF, Kassab SL, Pittock SJ. Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol 2006;63:1398-1400.
31. Pittock SJ, Lennon VA, de Seze J, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008;65:78-83.
32. Jarius S, Jacobi C, de Seze J, et al. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 2011;17:1067-1073.
33. Wingerchuk DM, Weinshenker BG. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 2012;18:5-10.